New boss brings diagnostic edge to PEB

New boss brings diagnostic edge to PEB
Peter Meintjes has experience in the global molecular diagnostics sectors relevant to Pacific Edge’s Cxbladder products. (Image: Supplied)
Dan Brunskill
Pacific Edge has appointed a molecular diagnostics expert to lead the cancer diagnostics company after the retirement of long-serving chief executive David Darling.The new CEO, Peter Meintjes, has a PhD in biological sciences from Auckland University and has been chief commercial officer of US-based organ transplant testing company Eurofins Transplant Genomics.Prior to that he served as chief executive of Hungary-based Omixon, another global molecular diagnostics company focused on organ and recipient compatibility testing.Pacific Edge said whi...

More Markets

NZ sharemarket closes lower, tech stocks buoyed by Oracle update
Markets Market Close

NZ sharemarket closes lower, tech stocks buoyed by Oracle update

The S&P/NZX 50 Index closed down 0.35% or 47.09 points.

Tom Raynel 11 Sep 2025
Average home insurance tops $2,000
Infrastructure Risky Business

Average home insurance tops $2,000

Insurance premiums in New Zealand have increased dramatically in recent years.

Michael Neilson 11 Sep 2025
How RFK Jnr's Medicare reform could aid this NZ firm
Markets

How RFK Jnr's Medicare reform could aid this NZ firm

'Wild west' conditions hampered its US push. They could be changing.